This document is an excerpt from the EUR-Lex website
Document 32010M6008
Commission Decision of 29/10/2010 declaring a concentration to be compatible with the common market (Case No COMP/M.6008 - IK / GHD) according to Council Regulation (EC) No 139/2004 (Only the English text is authentic)
Decisión de la Comisión, de 29/10/2010 por la que se declara la compatibilidad de una operación de concentración con el mercado común (Asunto no COMP/M.6008 - IK / GHD) sobre la base del Reglamento (CE) n. 139/2004 del Consejo (El texto en lengua inglesa es el único auténtico)
Decisión de la Comisión, de 29/10/2010 por la que se declara la compatibilidad de una operación de concentración con el mercado común (Asunto no COMP/M.6008 - IK / GHD) sobre la base del Reglamento (CE) n. 139/2004 del Consejo (El texto en lengua inglesa es el único auténtico)
In force
32010M6008
Commission Decision of 29/10/2010 declaring a concentration to be compatible with the common market (Case No COMP/M.6008 - IK / GHD) according to Council Regulation (EC) No 139/2004 (Only the English text is authentic)
(.PICT.) |EUROPEAN COMMISSION | Brussels , 29.10.2010 SG-Greffe(2010) D/17251 C(2010) 7663 PUBLIC VERSION MERGER PROCEDURE ARTICLE 6(1)(b) DECISION SIMPLIFIED PROCEDURE To the notifying party: Dear Madam(s) and/or Sir(s), Subject: Case No COMP/M.6008 – IK/ GHD Notification of 29/09/2010 pursuant to Article 4 of Council Regulation (EC) No 139/2004 [1] Publication in the Official Journal of the European Union No C 273, 09/10/2010, p.4 1. On 29/09/2010 the European Commission received notification of a proposed concentration pursuant to Article 4 of the Merger Regulation by which the IK Investment Partners ("IK", the Netherlands) acquire(s) within the meaning of Article 3(1)(b) of the EC Merger Regulation control of the whole of GHD GesundHeits GmbH Deutschland (GHD, Germany) by way of purchase of shares.The business activities of the undertakings concerned are: - IK: a European private equity investment firm; - GHD: active in the provision of medical devices and certain pharmaceutical products to non-hospitalized patients, wholesale of medical devices and pharmaceuticals, provision of logistic services in Germany, as well as production of compounded pharmaceuticals and ostomy products. 2. After examination of the notification, the European Commission has concluded that the notified operation falls within the scope of the Merger Regulation and of paragraph 5(b) of the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 [2] . 3. For the reasons set out in the Notice on a simplified procedure, the European Commission has decided not to oppose the notified operation and to declare it compatible with the internal market and with the EEA Agreement. This decision is adopted in application of Article 6(1)(b) of the Merger Regulation. For the European Commission, (Signed) Alexander ITALIANER Director General [1]OJ L 24, 29.1.2004, p. 1 ("the Merger Regulation"). With effect from 1 December 2009, the Treaty on the Functioning of the European Union ("TFEU") has introduced certain changes, such as the replacement of "Community" by "Union" and "common market" by "internal market". The terminology of the TFEU will be used throughout this decision. [2] OJ C 56, 5.3.2005, p. 32.